Nextgen Biomed Ltd (TLV:NXGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA 55.50
+1.00 (1.83%)
Jun 12, 2025, 5:24 PM IDT
Nextgen Biomed Market Cap
Nextgen Biomed has a market cap or net worth of 6.04 million as of June 13, 2025. Its market cap has decreased by -17.60% in one year.
Market Cap
6.04M
Enterprise Value
6.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
55.50
Market Cap Chart
Since July 17, 2013, Nextgen Biomed's market cap has decreased from 18.97M to 6.04M, a decrease of -68.18%. That is a compound annual growth rate of -9.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 70.16B |
| Danel (Adir Yeoshua) | 2.52B |
| Kamada | 1.41B |
| Bait Bakfar | 1.05B |
| BrainsWay | 763.73M |
| SofWave Medical | 731.12M |
| Novolog (Pharm-Up 1966) | 702.92M |
| Ilex Medical | 670.84M |